Genesee & Wyoming (GWR) PT Lowered to $70.00 at Morgan Stanley

Share on StockTwits

Genesee & Wyoming (NYSE:GWR) had its price target cut by Morgan Stanley from $73.00 to $70.00 in a research report sent to investors on Monday. They currently have an underweight rating on the transportation company’s stock.

GWR has been the topic of several other research reports. Stifel Nicolaus set a $93.00 price objective on shares of Genesee & Wyoming and gave the stock a buy rating in a report on Thursday, November 1st. ValuEngine upgraded shares of Genesee & Wyoming from a hold rating to a buy rating in a report on Tuesday, September 18th. Credit Suisse Group downgraded shares of Genesee & Wyoming from an outperform rating to an underperform rating and lowered their price objective for the stock from $90.00 to $71.00 in a report on Friday, November 2nd. JPMorgan Chase & Co. downgraded shares of Genesee & Wyoming from an overweight rating to a neutral rating in a report on Friday, October 12th. Finally, Cowen restated a buy rating and set a $92.00 price objective on shares of Genesee & Wyoming in a report on Wednesday, October 31st. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. Genesee & Wyoming currently has an average rating of Hold and an average price target of $86.60.

Genesee & Wyoming stock opened at $77.05 on Monday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.22 and a current ratio of 1.33. Genesee & Wyoming has a 12-month low of $67.61 and a 12-month high of $92.91. The firm has a market cap of $4.36 billion, a P/E ratio of 26.48, a P/E/G ratio of 0.93 and a beta of 1.66.

Genesee & Wyoming (NYSE:GWR) last released its quarterly earnings data on Tuesday, October 30th. The transportation company reported $1.23 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.07. Genesee & Wyoming had a net margin of 26.25% and a return on equity of 5.81%. The firm had revenue of $603.30 million for the quarter, compared to the consensus estimate of $594.40 million. During the same quarter in the prior year, the company posted $0.81 earnings per share. The business’s revenue was up 4.6% on a year-over-year basis. On average, equities research analysts expect that Genesee & Wyoming will post 3.76 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Ancora Advisors LLC bought a new stake in shares of Genesee & Wyoming in the 3rd quarter worth $100,000. FCA Corp TX bought a new stake in shares of Genesee & Wyoming in the 3rd quarter worth $205,000. Cadence Capital Management LLC bought a new stake in shares of Genesee & Wyoming in the 3rd quarter worth $214,000. First Wilshire Securities Management Inc. bought a new stake in shares of Genesee & Wyoming in the 2nd quarter worth $203,000. Finally, Virtu Financial LLC bought a new stake in shares of Genesee & Wyoming in the 3rd quarter worth $279,000. Hedge funds and other institutional investors own 93.11% of the company’s stock.

Genesee & Wyoming Company Profile

Genesee & Wyoming Inc owns and leases freight railroads. It operates through three segments: North American Operations, Australian Operations, and U.K./European Operations. The company transports various commodities, including agricultural products, autos and auto parts, chemicals and plastics, coal and coke, food and kindred products, lumber and forest products, metallic ores, metals, minerals and stone, petroleum products, pulp and paper, waste, and other commodities.

Further Reading: Institutional Investors

Analyst Recommendations for Genesee & Wyoming (NYSE:GWR)

Receive News & Ratings for Genesee & Wyoming Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesee & Wyoming and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Loxo Oncology Inc  Given Consensus Rating of “Buy” by Brokerages
Loxo Oncology Inc Given Consensus Rating of “Buy” by Brokerages
Brokerages Expect Intuit Inc.  Will Announce Quarterly Sales of $1.48 Billion
Brokerages Expect Intuit Inc. Will Announce Quarterly Sales of $1.48 Billion
Envion  One Day Volume Tops $1,493.00
Envion One Day Volume Tops $1,493.00
Mercury Reaches 24-Hour Volume of $202,462.00
Mercury Reaches 24-Hour Volume of $202,462.00
Shoe Carnival, Inc.  Given Average Rating of “Buy” by Analysts
Shoe Carnival, Inc. Given Average Rating of “Buy” by Analysts
Analysts Expect Neptune Wellness Solutions Inc  to Announce $0.00 EPS
Analysts Expect Neptune Wellness Solutions Inc to Announce $0.00 EPS


© 2006-2019 Ticker Report